Signature Diagnostics AG to Present Detector C 2.0 - A Blood Test for Early Detection of Colorectal Cancer at the American Society of Clinical Oncology 2012 Gastrointestinal Cancer Symposium in San Francisco
1/20/2012 12:00:07 PM
More...
|
Signature Diagnostics AG to Present at the 23rd Annual Piper Jaffray Health Care Conference
11/28/2011 9:13:11 AM
More...
|
Signature Diagnostics AG to Present a Novel Companion Diagnostic Product Predicting Response to Cetuximab in Colorectal Cancer at the 102nd American Association for Cancer Research Meeting in Orlando
4/6/2011 9:05:38 AM
More...
|
Signature Diagnostics AG Receives Extended Patent Protection for its Proteasome-Complex Inhibitors
12/7/2010 11:02:31 AM
More...
|
Signature Diagnostics AG to Present Company's Blood-Based Colorectal Cancer Screening Strategy at the 18th UEGW Congress in Barcelona
10/27/2010 8:31:12 AM
More...
|
Signature Diagnostics AG Appoints Rainer Kramer to Chief Business Officer and Member of the Management Board
9/30/2010 9:27:43 AM
More...
|
Signature Diagnostics AG Presents Positive Colorectal Screening Study Results at the 12th World Congress on Gastrointestinal Cancer in Barcelona
7/8/2010 1:38:47 PM
More...
|
Signature Diagnostics AG to Use Affymetrix (Bedford, Massachusetts) (AFFX) Microarray Technology for Advanced Colorectal Cancer Tests
6/28/2010 7:40:18 AM
More...
|
Signature Diagnostics AG Announces Positive Study Results for Detector C, Its Non-Invasive, Blood-Based IVD Screening Test for Early Detection of Colorectal Cancer
6/4/2010 11:42:48 AM
More...
|
Signature Diagnostics AG Raised 5.1 Mio EURO in a Series C Financing Round
8/18/2008 11:43:54 AM
More...
|
|